
Comparative statistics by cancer registry
Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
(Incheon, South Korea, 1997-2001 cases followed-up until 2002)Click on cancer site (ICD-10 code) for comparison
Site | ICD-10 | Total | Absolute survival % | Relative survival % | ASRS% at 5-years | ||||||
1-year | 3-year | 5-year | 1-year | 3-year | 5-year | all ages | 0-74 years | ||||
C01-02 | Tongue | 50 | 61.5 | 47.1 | 40.6 | 63.0 | 49.8 | 44.2 | 44.7 | 52.0 | |
C03-06 | Oral cavity | 64 | 61.8 | 48.7 | 45.5 | 63.5 | 52.4 | 50.7 | 51.3 | 54.4 | |
C07-08 | Salivary gland | 49 | 86.3 | 70.5 | 63.3 | 87.9 | 74.4 | 69.3 | 66.9 | 69.7 | |
C09 | Tonsil | 27 | 74.1 | 47.9 | 40.5 | 75.8 | 50.9 | 44.5 | 42.3 | 48.4 | |
C11 | Nasopharynx | 74 | 77.0 | 56.5 | 53.5 | 77.7 | 57.9 | 55.9 | 45.2 | 53.6 | |
C12-13 | Hypopharynx | 51 | 60.8 | 41.8 | 29.1 | 62.5 | 45.0 | 32.7 | 37.1 | 38.3 | |
C15 | Oesophagus | 304 | 39.9 | 20.4 | 17.7 | 41.1 | 22.4 | 21.3 | 21.7 | 25.9 | |
C16 | Stomach | 4293 | 61.2 | 46.7 | 41.9 | 62.7 | 49.9 | 47.0 | 42.9 | 50.0 | |
C17 | Small intestine | 81 | 51.2 | 40.8 | 34.1 | 52.5 | 43.4 | 37.5 | 34.6 | 47.7 | |
C18 | Colon | 1120 | 69.6 | 54.7 | 48.7 | 71.4 | 58.6 | 54.5 | 49.5 | 57.4 | |
C19-20 | Rectum | 1122 | 77.7 | 58.7 | 49.6 | 79.4 | 62.6 | 55.4 | 46.7 | 57.6 | |
C22 | Liver | 2328 | 32.4 | 18.6 | 14.9 | 33.0 | 19.6 | 16.3 | 16.0 | 16.8 | |
C23-24 | Gall bladder | 506 | 39.3 | 21.7 | 17.5 | 40.5 | 23.7 | 20.3 | 22.5 | 25.3 | |
C25 | Pancreas | 518 | 21.9 | 11.9 | 11.0 | 22.5 | 12.7 | 12.3 | 11.3 | 14.2 | |
C30-31 | Nose/Sinuses | 50 | 76.9 | 63.1 | 56.5 | 78.6 | 67.4 | 62.6 | 73.9 | 63.4 | |
C32 | Larynx | 222 | 65.2 | 53.5 | 48.1 | 67.0 | 58.0 | 55.2 | 55.5 | 61.6 | |
C33-34 | Lung | 2566 | 34.0 | 17.5 | 15.5 | 35.2 | 19.1 | 18.3 | 18.4 | 20.6 | |
C37-38 | Other thoracic organs | 56 | 54.5 | 38.3 | 30.7 | 55.7 | 41.0 | 34.2 | 31.2 | 32.5 | |
C40-41 | Bone | 104 | 73.9 | 67.2 | 59.9 | 74.9 | 69.1 | 63.0 | 43.2 | 46.9 | |
C43 | Melanoma skin | 45 | 80.0 | 64.0 | 64.0 | 81.6 | 68.3 | 72.5 | 71.0 | 71.5 | |
C44 | Other skin | 264 | 85.9 | 74.0 | 69.7 | 88.8 | 81.7 | 83.3 | 83.0 | 85.4 | |
C47+C49 | Connective tissue | 135 | 80.4 | 67.4 | 55.1 | 81.4 | 69.6 | 58.5 | 53.5 | 55.6 | |
C48 | Peritoneum | 54 | 54.4 | 35.7 | 30.0 | 55.7 | 37.8 | 33.4 | 31.1 | 28.4 | |
C50 | Breast | 1445 | 91.3 | 82.6 | 77.3 | 91.8 | 83.9 | 79.3 | 74.3 | 78.5 | |
C53 | Cervix | 1298 | 90.1 | 81.5 | 76.3 | 90.8 | 83.1 | 78.9 | 73.8 | 79.5 | |
C54 | Corpus uteri | 140 | 89.3 | 85.0 | 80.2 | 90.0 | 87.0 | 83.6 | 82.2 | 72.3 | |
C55 | Uterus unspecified | 33 | 14.9 | 14.9 | 14.9 | 15.2 | 15.3 | 15.4 | 19.1 | 26.2 | |
C56 | Ovary | 390 | 78.3 | 65.7 | 58.0 | 79.1 | 67.2 | 60.3 | 52.7 | 58.7 | |
C61 | Prostate | 282 | 78.6 | 58.1 | 50.4 | 82.9 | 67.9 | 65.5 | 63.5 | 69.4 | |
C62 | Testis | 29 | 100.0 | 96.1 | 96.1 | 100.3 | 97.1 | 97.7 | 98.3 | 98.3 | |
C64 | Kidney | 279 | 74.7 | 65.1 | 61.1 | 76.2 | 68.7 | 66.9 | 64.4 | 67.9 | |
C65 | Renal pelvis | 34 | 82.4 | 63.9 | 47.9 | 84.1 | 68.0 | 53.2 | 61.4 | 72.3 | |
C66 | Ureter | 33 | 76.5 | 69.8 | 69.8 | 79.0 | 77.2 | 83.3 | 87.2 | 91.0 | |
C67 | Urinary bladder | 467 | 78.0 | 65.5 | 60.1 | 80.7 | 72.1 | 71.0 | 65.9 | 76.1 | |
C70-72 | Brain & nervous system | 333 | 56.5 | 43.7 | 38.5 | 57.2 | 44.9 | 40.0 | 39.6 | 41.0 | |
C73 | Thyroid | 712 | 93.8 | 91.5 | 89.4 | 94.5 | 93.3 | 92.2 | 90.0 | 92.6 | |
C74 | Adrenal gland | 30 | 75.0 | 54.8 | 54.8 | 75.4 | 55.5 | 56.1 | 86.1 | 78.4 | |
C81 | Hodgkin lymphoma | 28 | 85.7 | 81.3 | 81.3 | 86.3 | 82.6 | 83.2 | 81.1 | 82.8 | |
C82-85+C96 | Non-Hodgkin lymphoma | 483 | 70.3 | 53.0 | 50.9 | 71.4 | 55.2 | 54.2 | 53.8 | 57.4 | |
C90 | Multiple myeloma | 89 | 56.2 | 33.7 | 25.3 | 57.3 | 35.9 | 28.4 | 27.2 | 29.0 | |
C91 | Lymphoid leukaemia | 125 | 67.2 | 50.2 | 50.2 | 67.5 | 50.7 | 50.8 | 38.1 | 40.3 | |
C92-94 | Myeloid leukaemia | 250 | 62.6 | 42.4 | 38.3 | 63.1 | 43.4 | 39.9 | 38.8 | 36.0 |
Graphs:
![]() |
Other tables available for this registry:
- Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Incheon, South Korea, 1997-2001 cases followed-up until 2002) |
- Table2b: | Number and proportion of cases by vital status and median follow-up (in months) by site (Incheon, Korea, 1997-2001 cases followed-up until 2002) |
- Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Incheon, South Korea, 1997-2001 cases followed-up until 2002) |
- Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Incheon, South Korea, 1997-2001 cases followed-up until 2002) |
Registry chapter:
![]() | Consult the chapter in Cancer survival in developping countries (Volume II) |